Clinical TrialID 7541
Efficacy and Safety of Topical Cysteamine for Postinflammatory Hyperpigmentation
NCT05206318
Hyperpigmentation; Postinflammatory
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 7541
- Evidence Id
- 7541
- Core Evidence Id
- 7541
- Source Clinical Trial Id
- 7536
- Herb2 Clinical Trial Id
- HBCT007536
- Nct Id
- NCT05206318
- Title
- Efficacy and Safety of Topical Cysteamine for Postinflammatory Hyperpigmentation
- Status
- Phase
- Study Result
- No
- Study Condition
- Hyperpigmentation; Postinflammatory
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
- Intervention
- DRUG: Topical Cysteamine|DRUG: Topical Vehicle Control
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Double
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 40
- Outcome Measure
- Change from Baseline Pigmentation at 4 Weeks, Patients will have their lesion pigmentation scored with the hyperpigmentation index after 4 weeks, 4 weeks|Change from Baseline Pigmentation at 8 Weeks, Patients will have their lesion pigmentation scored with the hyperpigmentation index after 8 weeks, 8 weeks|Change from Baseline Pigmentation at 12 Weeks, Patients will have their lesion pigmentation scored with the hyperpigmentation index after 12 weeks, 12 weeks|Change from Baseline Pigmentation at 16 Weeks, Patients will have their lesion pigmentation scored with the hyperpigmentation index after 16 weeks, 16 weeks
- Sponsor Collaborator
- Chang Gung Memorial Hospital|Scientis Pharma SA
- Funded By
- OTHER
- Location
- Linkou Chang Gung Memorial Hospital, Taoyuan City, 33305, Taiwan
- Other Id
- IRB202101456A3
- Start Date
- 2021-12-10
- Primary Completion Date
- 2022-06-10
- Completion Date
- 2022-12-10
- First Posted
- 2022-01-25
- Results First Posted
- Last Update Posted
- 2022-01-25
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT05206318
- Title Cn
- Title En
- Efficacy and Safety of Topical Cysteamine for Postinflammatory Hyperpigmentation
- Bilingual Status
- semi_complete